Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded Study of Curcumin With Pre-operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer

NCT00745134 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00745134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00745134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded Study of Curcumin With Pre-operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Terminated
Start date
August 11, 2008
Completion date
November 11, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal mucinous adenocarcinoma, rectal signet ring cell adenocarcinoma, recurrent rectal carcinoma, stage iia rectal cancer ajcc v7, stage iib rectal cancer ajcc v7, stage iic rectal cancer ajcc v7, stage iiia rectal cancer ajcc v7, stage iiib rectal cancer ajcc v7, stage iiic rectal cancer ajcc v7